Distinguished in Vascular Birthmark

Dr. Joyce Teng

Pediatrics
Lucille Packard Children's Hospital 030962
770 Welch Rd, 
Palo Alto, CA 
Distinguished in Vascular Birthmark
Lucille Packard Children's Hospital 030962
770 Welch Rd, 
Palo Alto, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joyce Teng is a Pediatrics provider in Palo Alto, California. Dr. Teng is rated as a Distinguished provider by MediFind in the treatment of Vascular Birthmark. Her top areas of expertise are Nevoid Basal Cell Carcinoma Syndrome, Dowling-Meara Epidermolysis Bullosa Simplex, Dominant Dystrophic Epidermolysis Bullosa, Fetal Retinoid Syndrome, and Liver Embolization.

Her clinical research consists of co-authoring 117 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Vascular Birthmark.

Specialties
Pediatrics
Licenses
Dermatology in CA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Contra Costa Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Health Plan of San Mateo
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Highmark
  • EPO
  • HMO
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Valley Health
  • HMO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 17 Less Insurance Carriers -

Locations

Lucille Packard Children's Hospital 030962
770 Welch Rd, Palo Alto, CA 94304
Call: 650-721-1227
Other Locations
Lucile Packard Children's Hospital Stanford
725 Welch Rd, Palo Alto, CA 94304
Call: 650-497-8000

Additional Areas of Focus

Dr. Teng has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Managed Access Program (MAP) Cohort Treatment Plan CBYL719F12001M to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Managed Access Program (MAP) Cohort Treatment Plan CBYL719F12001M to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Enrollment Status: Available
Publish Date: December 02, 2025
Intervention Type: Drug
Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis
Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis
Enrollment Status: Completed
Publish Date: March 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
Enrollment Status: Completed
Publish Date: August 29, 2024
Intervention Type: Drug
Study Drug: QTORIN rapamycin anhydrous gel
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase I/II, Closed Label, Randomized, Pilot Study for the Safety and Efficacy of TolaSure Gel, 5% w/w Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (TAMES)
A Phase I/II, Closed Label, Randomized, Pilot Study for the Safety and Efficacy of TolaSure Gel, 5% w/w Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (TAMES)
Enrollment Status: Completed
Publish Date: September 11, 2023
Intervention Type: Drug
Study Drug: TolaSure
Study Phase: Phase 1
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations
Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations
Enrollment Status: Completed
Publish Date: November 17, 2022
Intervention Type: Drug, Other
Study Drug: Sildenafil
Study Phase: Phase 2
Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations
Enrollment Status: Terminated
Publish Date: August 04, 2022
Intervention Type: Drug
Study Drug: VT30
Study Phase: Phase 1/Phase 2
A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Sirolimus 2% in the Treatment of Plantar Blistering in Patients With Epidermolysis Bullous Simplex (EBS)
A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Sirolimus 2% in the Treatment of Plantar Blistering in Patients With Epidermolysis Bullous Simplex (EBS)
Enrollment Status: Completed
Publish Date: March 09, 2022
Intervention Type: Drug
Study Drugs: Sirolimus, Vehicle
Study Phase: Phase 2
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex
Enrollment Status: Terminated
Publish Date: November 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

114 Total Publications

Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity.
Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity.
Journal: JAMA dermatology
Published: October 15, 2025
View All 114 Publications
Similar Doctors
Distinguished in Vascular Birthmark
Dr. Dawn Siegel
Pediatrics
Distinguished in Vascular Birthmark
Dr. Dawn Siegel
Pediatrics

Child And Adolescent Mental Health-Stanford Children's Health Specialty Services-Sunnyvale

1195 W Fremont Ave, 
Sunnyvale, CA 
 (8.5 miles away)
650-721-1227
Languages Spoken:
English
See accepted insurances

Dawn Siegel is a Pediatrics provider in Sunnyvale, California. Dr. Siegel is rated as an Elite provider by MediFind in the treatment of Vascular Birthmark. Her top areas of expertise are PHACE Syndrome, Hemangioma, Aplasia Cutis Congenita, and Vascular Birthmark.

Distinguished in Vascular Birthmark
Dr. Ilona Frieden
Pediatrics
Distinguished in Vascular Birthmark
Dr. Ilona Frieden
Pediatrics

Office

1701 Divisadero St # 340, 
San Francisco, CA 
 (28.2 miles away)
415-353-7800
Languages Spoken:
English
See accepted insurances

Ilona Frieden is a Pediatrics provider in San Francisco, California. Dr. Frieden is rated as an Elite provider by MediFind in the treatment of Vascular Birthmark. Her top areas of expertise are PHACE Syndrome, Hemangioma, Clouston Syndrome, and Ectodermal Dysplasias.

Advanced in Vascular Birthmark
Dr. Ann Marqueling
Pediatrics
Advanced in Vascular Birthmark
Dr. Ann Marqueling
Pediatrics

Office

770 Welch Rd Ste 300, 
Palo Alto, CA 
 (4.3 miles away)
650-721-1227
Languages Spoken:
English
See accepted insurances

Ann Marqueling is a Pediatrics provider in Palo Alto, California. Dr. Marqueling is rated as an Advanced provider by MediFind in the treatment of Vascular Birthmark. Her top areas of expertise are Stork Bite, Vascular Birthmark, Linear Hamartoma Syndrome, and Familial Multiple Nevi Flammei.

VIEW MORE VASCULAR BIRTHMARK DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Teng's expertise for a condition
ConditionClose
    • Distinguished
    • Aplasia Cutis Congenita
      Dr. Teng is
      Distinguished
      . Learn about Aplasia Cutis Congenita.
      See more Aplasia Cutis Congenita experts
    • Arteriovenous Malformation
      Dr. Teng is
      Distinguished
      . Learn about Arteriovenous Malformation.
      See more Arteriovenous Malformation experts
    • Dominant Dystrophic Epidermolysis Bullosa
      Dr. Teng is
      Distinguished
      . Learn about Dominant Dystrophic Epidermolysis Bullosa.
      See more Dominant Dystrophic Epidermolysis Bullosa experts
    • Dowling-Meara Epidermolysis Bullosa Simplex
      Dr. Teng is
      Distinguished
      . Learn about Dowling-Meara Epidermolysis Bullosa Simplex.
      See more Dowling-Meara Epidermolysis Bullosa Simplex experts
    • Epidermal Nevus
      Dr. Teng is
      Distinguished
      . Learn about Epidermal Nevus.
      See more Epidermal Nevus experts
    • Epidermolysis Bullosa
      Dr. Teng is
      Distinguished
      . Learn about Epidermolysis Bullosa.
      See more Epidermolysis Bullosa experts
    View All 15 Distinguished Conditions
    • Advanced
    • 2q37 Deletion Syndrome
      Dr. Teng is
      Advanced
      . Learn about 2q37 Deletion Syndrome.
      See more 2q37 Deletion Syndrome experts
    • Aase Syndrome
      Dr. Teng is
      Advanced
      . Learn about Aase Syndrome.
      See more Aase Syndrome experts
    • Abdominal Cystic Lymphangioma
      Dr. Teng is
      Advanced
      . Learn about Abdominal Cystic Lymphangioma.
      See more Abdominal Cystic Lymphangioma experts
    • Abruzzo-Erickson Syndrome
      Dr. Teng is
      Advanced
      . Learn about Abruzzo-Erickson Syndrome.
      See more Abruzzo-Erickson Syndrome experts
    • Acrodermatitis Enteropathica
      Dr. Teng is
      Advanced
      . Learn about Acrodermatitis Enteropathica.
      See more Acrodermatitis Enteropathica experts
    • Acrokeratoelastoidosis of Costa
      Dr. Teng is
      Advanced
      . Learn about Acrokeratoelastoidosis of Costa.
      See more Acrokeratoelastoidosis of Costa experts
    View All 121 Advanced Conditions
    • Experienced
    • Acanthosis Nigricans
      Dr. Teng is
      Experienced
      . Learn about Acanthosis Nigricans.
      See more Acanthosis Nigricans experts
    • Acne
      Dr. Teng is
      Experienced
      . Learn about Acne.
      See more Acne experts
    • Acrogeria, Gottron Type
      Dr. Teng is
      Experienced
      . Learn about Acrogeria, Gottron Type.
      See more Acrogeria, Gottron Type experts
    • Actinic Keratosis
      Dr. Teng is
      Experienced
      . Learn about Actinic Keratosis.
      See more Actinic Keratosis experts
    • AEC Syndrome
      Dr. Teng is
      Experienced
      . Learn about AEC Syndrome.
      See more AEC Syndrome experts
    • Alopecia Totalis
      Dr. Teng is
      Experienced
      . Learn about Alopecia Totalis.
      See more Alopecia Totalis experts
    View All 135 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.